Back to Search
DAVID CUNNINGHAM, MD
MD
Anesthesiology Physician
NPI: 1912971359IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
22279(NE)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
OREGON HEALTH SCIENCES UNIVERSITY SCHOOL OF MEDICINE
Class of 2001
Research & Publications (20)
Cloning and developmental expression of the soxB2 genes, sox14 and sox21, during Xenopus laevis embryogenesis.
PMID 18956331·Int J Dev Biol·2008
7-preclinical
Host immunity modulates transcriptional changes in a multigene family (yir) of rodent malaria.
PMID 16238615·Mol Microbiol·2005
7-preclinical
Early radical prostatectomy improves disease-specific but not overall survival.
PMID 12540307·J Fam Pract·2003
8-other
Within-group human variation in the Asian Pleistocene: the three Upper Cave crania.
PMID 11969300·J Hum Evol·2002
4-observational
Adduct formation between alkali metal ions and divalent metal salicylaldimine complexes having methoxy substituents. A structural investigation.
PMID 12526548·Inorg Chem·2000
8-other
Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer.
PMID 19474114·Ann Oncol·2009
1-meta
Current perspective: bevacizumab in colorectal cancer--a time for reappraisal?
PMID 19643598·Eur J Cancer·2009
8-other
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.
PMID 19406901·Ann Oncol·2009
3-trial
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008.
PMID 19497945·Ann Oncol·2009
8-other
Validation of the Royal Marsden hospital prognostic index in advanced esophagogastric cancer using individual patient data from the REAL 2 study.
PMID 19470917·J Clin Oncol·2009
4-observational
Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
PMID 19454457·Ann Oncol·2009
6-review
Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO.
PMID 19450285·BMC Cancer·2009
3-trial
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.
PMID 19451425·J Clin Oncol·2009
3-trial
Fundus autofluorescence in type 2 idiopathic macular telangiectasia: correlation with optical coherence tomography and microperimetry.
PMID 19573860·Am J Ophthalmol·2009
4-observational
A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma.
PMID 19436301·Br J Cancer·2009
3-trial
Developmental expression pattern of the cholesterogenic enzyme NSDHL and negative selection of NSDHL-deficient cells in the heterozygous Bpa(1H)/+ mouse.
PMID 19631568·Mol Genet Metab·2009
7-preclinical
Complex training in professional rugby players: influence of recovery time on upper-body power output.
PMID 19675483·J Strength Cond Res·2009
8-other
Factors affecting plasmid production in Escherichia coli from a resource allocation standpoint.
PMID 19463175·Microb Cell Fact·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 BOONE RD
BREMERTON, WA 98312 - Phone
- (360) 475-4426
Quick Facts
- NPI
- 1912971359
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 25
- Publications
- 20
Are you this provider?
Claim Your Profile